Literature DB >> 18587448

Regulation of M2-type pyruvate kinase mediated by the high-affinity IgE receptors is required for mast cell degranulation.

H Ryu1, J K L Walker, S Kim, N Koo, L S Barak, T Noguchi, B Y Kang, K-M Kim.   

Abstract

BACKGROUND AND
PURPOSE: M2-type pyruvate kinase (M2PK) was found to interact directly with the 'ITAM' region of the gamma chain of the high-affinity IgE receptor (FcvarepsilonRI). Our hypothesis was that mast cell degranulation might require the FcvarepsilonRI-mediated inhibition of M2PK activity. EXPERIMENTAL APPROACH: In rat basophilic leukaemia (RBL-2H3) cells, the effects of directly inhibiting M2PK or preventing the FcvarepsilonRI-mediated inhibition of M2PK (disinhibition) on degranulation was measured by hexosaminidase release. Effects of blocking the FcvarepsilonRI-mediated inhibition of M2PK was also assessed in vivo in a mouse model of allergen-induced airway hyper-responsiveness. KEY
RESULTS: Activation of FcvarepsilonRI in RBL-2H3 cells caused the rapid phosphorylation of tyrosine residues in M2PK, associated with a decrease in M2PK enzymatic activity. There was an inverse correlation between M2PK activity and mast cell degranulation. FcvarepsilonRI-mediated inhibition of M2PK involved Src kinase, phosphatidylinositol 3-kinase, PKC and calcium. Direct inhibition of M2PK potentiated FcvarepsilonRI-mediated degranulation and prevention of the FcvarepsilonRI-mediated inhibition of M2PK attenuated mast cell degranulation. Transfection of RBL-2H3 cells with M1PK which prevents FcvarepsilonRI-induced inhibition of M2PK, markedly reduced their degranulation and exogenous M1PK (i.p.) inhibited ovalbumin-induced airway hyper-responsiveness in vivo. CONCLUSIONS AND IMPLICATIONS: We have identified a new control point and a novel biochemical pathway in the process of mast cell degranulation. Our study suggests that the FcvarepsilonRI-mediated inhibition of M2PK is a crucial step in responses to allergens. Moreover, the manipulation of glycolytic processes and intermediates could provide novel strategies for the treatment of allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18587448      PMCID: PMC2451040          DOI: 10.1038/bjp.2008.148

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

1.  Effects of resveratrol on mast cell degranulation and tyrosine phosphorylation of the signaling components of the IgE receptor.

Authors:  NaYeon Koo; DongIm Cho; YoungRan Kim; Hyun Jin Choi; Kyeong-Man Kim
Journal:  Planta Med       Date:  2006-04-24       Impact factor: 3.352

2.  Complete structure and expression in transfected cells of high affinity IgE receptor.

Authors:  U Blank; C Ra; L Miller; K White; H Metzger; J P Kinet
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

3.  The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing.

Authors:  T Noguchi; H Inoue; T Tanaka
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

4.  Rat pyruvate kinase M gene. Its complete structure and characterization of the 5'-flanking region.

Authors:  M Takenaka; T Noguchi; H Inoue; K Yamada; T Matsuda; T Tanaka
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

5.  Pyruvate kinase type M2 is phosphorylated at tyrosine residues in cells transformed by Rous sarcoma virus.

Authors:  P Presek; M Reinacher; E Eigenbrodt
Journal:  FEBS Lett       Date:  1988-12-19       Impact factor: 4.124

6.  Antigen receptor tail clue.

Authors:  M Reth
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

7.  Expression of airway hyperreactivity to acetylcholine as a simple autosomal recessive trait in mice.

Authors:  R C Levitt; W Mitzner
Journal:  FASEB J       Date:  1988-07       Impact factor: 5.191

8.  [Changes in certain enzymes of anaerobic glycolysis and pentose cycle in atopic eczema (author's transl)].

Authors:  L Buchtová; O Cech
Journal:  Cesk Dermatol       Date:  1982-02

9.  Pyruvate kinase isozymes from rat.

Authors:  K Imamura; T Tanaka
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

10.  Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness.

Authors:  R J Smith; L M Sam; J M Justen; G L Bundy; G A Bala; J E Bleasdale
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

View more
  14 in total

Review 1.  Human pyruvate kinase M2: a multifunctional protein.

Authors:  Vibhor Gupta; Rameshwar N K Bamezai
Journal:  Protein Sci       Date:  2010-11       Impact factor: 6.725

2.  Cutting Edge: Murine Mast Cells Rapidly Modulate Metabolic Pathways Essential for Distinct Effector Functions.

Authors:  Binh Phong; Lyndsay Avery; Ashley V Menk; Greg M Delgoffe; Lawrence P Kane
Journal:  J Immunol       Date:  2016-12-14       Impact factor: 5.422

3.  Dominant negative mutations affect oligomerization of human pyruvate kinase M2 isozyme and promote cellular growth and polyploidy.

Authors:  Vibhor Gupta; Ponnusamy Kalaiarasan; Mohammad Faheem; Nishant Singh; Mohammad Askandar Iqbal; Rameshwar N K Bamezai
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

4.  Missense mutations in pyruvate kinase M2 promote cancer metabolism, oxidative endurance, anchorage independence, and tumor growth in a dominant negative manner.

Authors:  Mohd Askandar Iqbal; Farid Ahmad Siddiqui; Noor Chaman; Vibhor Gupta; Bhupender Kumar; Prakasam Gopinath; Rameshwar N K Bamezai
Journal:  J Biol Chem       Date:  2014-02-03       Impact factor: 5.157

5.  Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer.

Authors:  Dipok Kumar Dhar; Steven W M Olde Damink; James Hal Brindley; Andrew Godfrey; Michael H Chapman; Neomal S Sandanayake; Fausto Andreola; Sybille Mazurek; Tayyaba Hasan; Massimo Malago; Stephen P Pereira
Journal:  Cancer       Date:  2012-08-01       Impact factor: 6.860

Review 6.  Role of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases.

Authors:  Charalambos Michaeloudes; Pankaj K Bhavsar; Sharon Mumby; Bingling Xu; Christopher Kim Ming Hui; Kian Fan Chung; Ian M Adcock
Journal:  J Innate Immun       Date:  2019-11-29       Impact factor: 7.349

7.  Polyamines are present in mast cell secretory granules and are important for granule homeostasis.

Authors:  Gianni García-Faroldi; Carlos E Rodríguez; José L Urdiales; José M Pérez-Pomares; José C Dávila; Gunnar Pejler; Francisca Sánchez-Jiménez; Ignacio Fajardo
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

8.  Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2.

Authors:  Mohd Askandar Iqbal; Farid Ahmad Siddiqui; Vibhor Gupta; Shilpi Chattopadhyay; Prakasam Gopinath; Bhupender Kumar; Siddharth Manvati; Noor Chaman; Rameshwar N K Bamezai
Journal:  Mol Cancer       Date:  2013-07-09       Impact factor: 27.401

Review 9.  Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases.

Authors:  Ibrahim AlZaim; Safaa H Hammoud; Houssam Al-Koussa; Alaa Ghazi; Ali H Eid; Ahmed F El-Yazbi
Journal:  Front Cardiovasc Med       Date:  2020-11-17

Review 10.  The Role Played by Mitochondria in FcεRI-Dependent Mast Cell Activation.

Authors:  Maria A Chelombitko; Boris V Chernyak; Artem V Fedorov; Roman A Zinovkin; Ehud Razin; Lakhsmi Bhargavi Paruchuru
Journal:  Front Immunol       Date:  2020-10-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.